Sofinnova Investments, Inc.

Q4 2018 13F Holdings Report, Restatement, Options Holdings

Signature - Title
Nathalie Auber - Attorney-in-Fact
Location
Menlo Park
Options holdings as of
December 31, 2018
Date filed
2/22/2019, 11:07 AM
Description
All US holdings of this investor are reported in this report.
Previous filing
Q3 2018 - Nov 15, 2018
Next filing
Q1 2019 - May 15, 2019
Stock holdings
Showing options holdings, see here for stock holdings
Sym Company Class Option Share Change Activity * Price $ Shares Notional Value
Filing 2018 Q4 - Restatement compared to 2018 Q3 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Nathalie Auber Attorney-in-Fact Menlo Park, California 2/21/2019

This Amendment No. 1 is being filed to report the holdings of Nucana plc (f/k/a Nucana Biomed Ltd) in a manner consistent with the Reporting Manager's previous Form 13F filing. For the avoidance of doubt, the Reporting Manager did not dispose of such securities between the filing of the previous Form 13F and this Amendment No. 1.Sofinnova Investments, Inc. is filing this Form 13F on behalf of itself and the general partner entities of the investment funds for which it serves as the investment adviser, Sofinnova Management VII, L.L.C., Sofinnova Management VIII, L.L.C., Sofinnova Management IX, L.L.C., Sofinnova Management X, L.L.C., and Sofinnova BioEquities GP LLC.

Other Included Managers (2):

Num Name File Number
1 Crestline Management, LP 028-14917
2 Blackstone Alternative Asset Management L.P.